Newron Pharmaceuticals to Participate in June Investor Conferences

Newron Pharmaceuticals to Participate in June Investor Conferences

Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral nervous system (CNS), today announced that Stefan Weber, CEO and Roberto Galli, CFO, will participate in the following investor conferences in June:

At the Jefferies Global Healthcare Conference, members of the Newron management team will participate in a corporate presentation and one-on-one investor meetings. The corporate presentation will take place on Thursday, June 4, 2026, at 2:00 p.m. ET.

At the H.C. Wainwright conference, members of the Newron team will participate virtually in a corporate presentation and one-on-one investor meetings. The pre-recorded corporate presentation will be available on-demand to registered conference attendees starting on June 15, 2026 at 7:00 A.M. (ET).

To schedule a meeting with management during the conferences, please contact Casey Darby at cdarby@lavoiegroup.com.